Neuroprotective effect of aqueous extract of Berberis vulgaris L. in a model of Parkinson's disease in rat

Journal of Medicinal Plants

Volumn 9, Issue 36, 2010, Pages

  Salar, F ^a   Ziai, S A ^b   Nasri, S ^a   Roghani, M ^c   Kamalinejad, M ^d  

^a PAYAME NOOR UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHED UNIVERSITY   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

6 OHDA; Angiotensin converting enzyme; Berberis vulgaris; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; BERBERIS VULGARIS EXTRACT; BRAIN PROTEIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROTOXIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BERBERIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; LEFT HEMISPHERE; LIPID PEROXIDATION; MALE; MUSCLE RIGIDITY; NEUROPROTECTION; NONHUMAN; OXIDATION; PARKINSON DISEASE; PROTEIN BLOOD LEVEL; RAT;

BERBERIS; BERBERIS VULGARIS; RATTUS;

EID: 79953855357     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lopez-Real A, Rey P, Soto-Otero R, Mendez-Alvarez E, Labandeira-Garcia JL. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism. J. Neurosci. Res. 2005; 81: 865-73.
2. Quinlan JT, Phillips MI. Immunoreactivity for an angiotensin II-like peptide in the human brain. Brain Res. 1981; 205: 212-8. (Pubitemid 11205768)
3. Mendelsohn FA, Jenkins TA, Berkovic SF. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res. 1993; 613: 221-9. (Pubitemid 23179972)
4. Griendling KK, Sorescu D, Ushio-Fukai M. NAD (P) H oxidase role in cardiovascular biology and disease. Circulation Res. 2000; 86: 494-501. (Pubitemid 30165039)
5. Jenner P. Oxidative stress as a cause of Parkinson's disease. Acta Neurologica Scandinavica 1991; 84: 6-15.
6. Ganong WF. Origin of the angiotensin II secreted by cells. Proc. Soc. Exp. Biol. Med. 1994; 205: 213-9.
7. Munzel T, Keaney JF, Jr. Are ACE inhibitors a "magic bullet" against oxidative stress? Circulation 2001; 104: 1571-4.
8. Sica DA. Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy: its role in clinical practice. J. Clin. Hypertens (Greenwich) 2003; 5: 414-20.
9. Allain H, Bentue-Ferrer D, Akwa Y. Disease-modifying drugs and Parkinson's disease. Prog Neurobiol 2008; 84: 25-39.
10. Reardon KA, Mendelsohn FA, Chai SY, Home MK. The angiotensin converting enzyme (ACE) inhibitor, Perindopril, modifies the clinical features of Parkinson's disease. Aust N. Z. J. Med. 2000; 30: 48-53.
11. Hanachi P, Golkho SH. Using HPLC to Determination the Composition and Antioxidant Activity of Berberis Vulgaris. Europ. J. Scientific Res. 2009; 29: 47-54.
12. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother. Res. 2008; 22: 999-1012.
13. Tomosaka H, Chin YW, Salim AA, Keller WJ, Chai H, Kinghom AD. Antioxidant and cytoprotective compounds from Berberis vulgaris (barberry). Phytother. Res. 2008; 22: 979-81.
14. Kanazawa I. Short review on monoamine oxidase and its inhibitors. Eur. Neurol. 1994; 34 Suppl 3: 36-9. (Pubitemid 24294544)
15. Bryant SG, Brown CS. Current concepts in clinical therapeutics: major affective disorders, Part 2. Clin Pharm 1986; 5: 385-95. (Pubitemid 16050711)
16. Thirupurasundari CJ, Padmini R, Devaraj SN. Effect of berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats. Chemico-biological interactions 2009; 177: 190-5.
17. Peng WH, Lo KL, Lee YH, Hung TH, Lin YC. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sci. 2007; 81: 933-8.
18. Cordell GA, Southon IW, Buckingham J: Dictionary of alkaloids. Chapman and Hall, 1989, pp:243-4.
19. Mann C, Staba EJ, Craker LE, Simon JE: Herbs, spices and medicinal plants: recent advances in botany, horticulture, and pharmacology. 1st edn. Food Products Press, 1986, pp:235-80.
20. De Smet P: Adverse effects of herbal drugs. Springer-Verlag Berlin and Heidelberg GmbH & Co. K, 1992, pp: 122-50.
21. Chun YT, Yip TT, Lau KL, Kong YC, Sankawa U. A biochemical study on the hypotensive effect of berberine in rats. Gen. Pharmacol. 1979; 10: 177-82.
22. Kang DG, Sohn EJ, Kwon EK, Han JH, Oh H, Lee HS. Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vascul Pharmacol. 2002; 39: 281-6. (Pubitemid 36830730)
23. Tsai CS, Ochillo RF. Pharmacological effects of berberine on the longitudinal muscle of the guinea-pig isolated ileum. Arch. Int. Pharmacodyn. Ther. 1991; 310: 116-31.
24. Castillo J, Hung J, Rodriguez M, Bastidas E, Laboren I, Jaimes A. LED fluorescence spectroscopy for direct determination of monoamine oxidase B inactivation. Anal Biochem. 2005; 343: 293-8. (Pubitemid 41074043)
25. Kong LD, Cheng CH, Tan RX. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Med. 2001; 67: 74-6. (Pubitemid 32199950)
26. Kim DK, Lee KT, Baek NI, Kim SH, Park HW, Lim JP, Shin TY, Eom DO, Yang JH, Eun JS. Acetylcholinesterase inhibitors from the aerial parts of Corydalis speciosa. Arch. Pharm. Res. 2004; 27: 1127-31.
27. Wang F, Zhao G, Cheng L, Zhou HY, Fu LY, Yao WX. Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain. Res. 2004; 999: 91-7.
28. Yokozawa T, Ishida A, Kashiwada Y, Cho EJ, Kim HY, Ikeshiro Y. Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components. J. Pharm. Pharmacol. 2004; 56: 547-56.
29. Shin JS, Kim EI, Kai M, Lee MK. Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 2000; 25: 363-8.
30. Montalleb G, Hanachi P, Kua SH, Fauziah O. Evaluation of phenolic content and total antioxidant activity in Berberis vulgaris fruit extract J Biol. Sci. 2005; 5: 618-53.